Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis

American Journal of Clinical Pathology

Volumn 140, Issue 1, 2013, Pages 73-81

  He, Hui ^a   Wu, Gang ^a   Liu, Haiyang ^a   Cheng, Ying ^a   Yu, Yanqiu ^a   Wang, Yawei ^a   Liu, Yongfeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ABL2; HCC; Hepatocellular carcinoma; Ras and Rab interactor 1; RIN1

Indexed keywords

ABELSON KINASE; ABL2 PROTEIN; RAS AND RAB INTERACTOR 1; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL INVASION; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ABL2; HCC; HEPATOCELLULAR CARCINOMA; RAS AND RAB INTERACTOR 1; RIN1;

CARCINOMA, HEPATOCELLULAR; CHINA; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84879440134     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPEGWYDD86WWJK     Document Type: Article

References (30)

1. Scartozzi M, Faloppi L, Bianconi M, et al. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PloS One. 2012;7:e32653.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576.
3. Geng M, Cao YC, Chen YJ, et al. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol. 2012;18:1328-1338.
4. Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093-5107.
5. Feng JT, Shang S, Beretta L. Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene. 2006;25:3810-3817.
6. Bliss JM, Venkatesh B, Colicelli J. The RIN family of Ras effectors. Methods Enzymol. 2006;407:335-344.
7. Tall GG, Barbieri MA, Stahl PD, et al. Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell. 2001;1:73-82.
8. Hu H, Bliss JM, Wang Y, et al. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol. 2005;15:815-823.
9. Kong C, Su X, Chen PI, et al. Rin1 interacts with signaltransducing adaptor molecule (STAM) and mediates epidermal growth factor receptor trafficking and degradation. J Biol Chem. 2007;282:15294-15301.
10. Barbieri MA, Kong C, Chen PI, et al. The SRC homology 2 domain of Rin1 mediates its binding to the epidermal growth factor receptor and regulates receptor endocytosis. J Biol Chem. 2003;278:32027-32036.
11. Wang Y, Waldron RT, Dhaka A, et al. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol Cell Biol 2002;22:916-926.
12. Milstein M, Mooser CK, Hu H, et al. RIN1 is a breast tumor suppressor gene. Cancer Res. 2007;67:11510-11516.
13. Thai M, Ting PY, McLaughlin J, et al. ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1. Leukemia. 2011;25:290-300.
14. Yu HF, Zhao G, Ge ZJ, et al. High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol. 2012;33:1557-1563.
15. Senda K, Goi T, Hirono Y, et al. Analysis of RIN1 gene expression in colorectal cancer. Oncol Rep. 2007;17:1171-1175.
16. Wang Q, Gao Y, Tang Y, et al. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer. Acta Histochem. 2012;114:463-468.
17. Shan GY, Zhang Z, Chen QG, et al. Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma. Tumour Biol. 2012;33:847-855.
18. Engers R, Mueller M, Walter A, et al. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer. 2006;95:1081-1086.
19. Colicelli J, Nicolette C, Birchmeier C, et al. Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1991;88:2913-2917.
20. Han L, Colicelli J. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol Cell Biol. 1995;15:1318-1323.
21. Hu H, Milstein M, Bliss JM, et al. Integration of transforming growth factor β and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factordirected cell migration. Mol Cell Biol. 2008;28:1573-1583.
22. Pendergast AM. The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res. 2002;85:51-100.
23. Noren NK, Foos G, Hauser CA, et al. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol. 2006;8:815-825.
24. Paksoy M, Hardal U, Caglar C. Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. J Cancer Res Clin Oncol. 2011;137:1371-1377.
25. Erdem H, Gundogdu C, Sipal S. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Exp Mol Pathol. 2011;90:312-317.
26. Rolli M, Fransvea E, Pilch J, et al. Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:9482-9487.
27. Laack E, Scheffler A, Burkholder I, et al. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 2005;50:51-58.
28. Li J, Lau GK, Chen L, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-κB induced matrix metalloproteinases 2 and 9 expression. PloS One. 2011;6:e21816.
29. Zhao XL, Sun T, Che N, et al. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med. 2011;15:691-700.
30. Feller SM. Crk family adaptors-signalling complex formation and biological roles. Oncogene. 2001;20:6348-6371.